Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

NIH

Sponsor class

Conditions

Vasculitis
Wegener's Granulomatosis

Interventions

DRUG: cyclophosphamide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)